Complement C5 protein as a marker of subclinical atherosclerosis

Background: The mechanisms underlying early atherosclerotic plaque formation are not completely understood. Moreover, plasma biomarkers of subclinical atherosclerosis are lacking. Objectives: The purpose of this study was to analyze the temporal and topologically resolved protein changes taking plac...

Descripción completa

Detalles Bibliográficos
Autores: Martínez-López, Diego, Roldán-Montero, Raquel, García-Marqués, Fernando, Núñez, Estefanía, Jorge, Inmaculada, Camafeita, Emilio, Mínguez, Pablo, Rodriguez de Córdoba, Santiago, López-Melgar, Beatriz, Lara-Pezzi, Enrique, Fernández-Ortiz, Antonio, Ibáñez, Borja, Valdivielso, José Manuel, Fuster Carulla, Valentí, Michel, Jean-Baptiste, Blanco-Colio, Luis Miguel, Vázquez, Jesús, Martín Ventura, José Luis
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/693219
Acceso en línea:http://hdl.handle.net/10486/693219
https://dx.doi.org/10.1016/j.jacc.2020.02.058
Access Level:acceso abierto
Palabra clave:Biomarkers
Complement system
Proteomics
Subclinical atherosclerosis
Medicina
id ES_6129ffde8ffa99c2fbf0c9ffc37968c1
oai_identifier_str oai:repositorio.uam.es:10486/693219
network_acronym_str ES
network_name_str España
repository_id_str
spelling Complement C5 protein as a marker of subclinical atherosclerosisMartínez-López, DiegoRoldán-Montero, RaquelGarcía-Marqués, FernandoNúñez, EstefaníaJorge, InmaculadaCamafeita, EmilioMínguez, PabloRodriguez de Córdoba, SantiagoLópez-Melgar, BeatrizLara-Pezzi, EnriqueFernández-Ortiz, AntonioIbáñez, BorjaValdivielso, José ManuelFuster Carulla, ValentíMichel, Jean-BaptisteBlanco-Colio, Luis MiguelVázquez, JesúsMartín Ventura, José LuisBiomarkersComplement systemProteomicsSubclinical atherosclerosisMedicinaBackground: The mechanisms underlying early atherosclerotic plaque formation are not completely understood. Moreover, plasma biomarkers of subclinical atherosclerosis are lacking. Objectives: The purpose of this study was to analyze the temporal and topologically resolved protein changes taking place in human aortas with early atherosclerosis to find new potential diagnostic and/or therapeutic targets. Methods: The protein composition of healthy aortas (media layer) or with early atheroma (fatty streak and fibrolipidic, media and intima layers) was analyzed by deep quantitative multiplexed proteomics. Further analysis was performed by Western blot, immunohistochemistry, real-time polymerase chain reaction, and enzyme-linked immunosorbent assay. Plasma levels of complement C5 were analyzed in relation to the presence of generalized (>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical cohorts (PESA [Progression of Early Subclinical Atherosclerosis] [n = 360] and NEFRONA [National Observatory of Atherosclerosis in Nephrology] [n = 394]). Results: Proteins involved in lipid transport, complement system, immunoglobulin superfamily, and hemostasis are increased in early plaques. Components from the complement activation pathway were predominantly increased in the intima of fibrolipidic plaques. Among them, increased C5 protein levels were further confirmed by Western blot, enzyme-linked immunosorbent assay and immunohistochemistry, and associated with in situ complement activation. Plasma C5 was significantly increased in individuals with generalized subclinical atherosclerosis in both PESA and NEFRONA cohorts, independently of risk factors. Moreover, in the PESA study, C5 plasma levels positively correlated with global plaque volume and coronary calcification. Conclusions: Activation of the complement system is a major alteration in early atherosclerotic plaques and is reflected by increased C5 plasma levels, which have promising value as a novel circulating biomarker of subclinical atherosclerosisElsevier Inc.Departamento de MedicinaFacultad de Medicina20202020-04-28research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10486/693219https://dx.doi.org/10.1016/j.jacc.2020.02.058reponame:Biblos-e Archivo. Repositorio Institucional de la UAMinstname:Universidad Autónoma de MadridInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:repositorio.uam.es:10486/6932192026-06-23T12:46:27Z
dc.title.none.fl_str_mv Complement C5 protein as a marker of subclinical atherosclerosis
title Complement C5 protein as a marker of subclinical atherosclerosis
spellingShingle Complement C5 protein as a marker of subclinical atherosclerosis
Martínez-López, Diego
Biomarkers
Complement system
Proteomics
Subclinical atherosclerosis
Medicina
title_short Complement C5 protein as a marker of subclinical atherosclerosis
title_full Complement C5 protein as a marker of subclinical atherosclerosis
title_fullStr Complement C5 protein as a marker of subclinical atherosclerosis
title_full_unstemmed Complement C5 protein as a marker of subclinical atherosclerosis
title_sort Complement C5 protein as a marker of subclinical atherosclerosis
dc.creator.none.fl_str_mv Martínez-López, Diego
Roldán-Montero, Raquel
García-Marqués, Fernando
Núñez, Estefanía
Jorge, Inmaculada
Camafeita, Emilio
Mínguez, Pablo
Rodriguez de Córdoba, Santiago
López-Melgar, Beatriz
Lara-Pezzi, Enrique
Fernández-Ortiz, Antonio
Ibáñez, Borja
Valdivielso, José Manuel
Fuster Carulla, Valentí
Michel, Jean-Baptiste
Blanco-Colio, Luis Miguel
Vázquez, Jesús
Martín Ventura, José Luis
author Martínez-López, Diego
author_facet Martínez-López, Diego
Roldán-Montero, Raquel
García-Marqués, Fernando
Núñez, Estefanía
Jorge, Inmaculada
Camafeita, Emilio
Mínguez, Pablo
Rodriguez de Córdoba, Santiago
López-Melgar, Beatriz
Lara-Pezzi, Enrique
Fernández-Ortiz, Antonio
Ibáñez, Borja
Valdivielso, José Manuel
Fuster Carulla, Valentí
Michel, Jean-Baptiste
Blanco-Colio, Luis Miguel
Vázquez, Jesús
Martín Ventura, José Luis
author_role author
author2 Roldán-Montero, Raquel
García-Marqués, Fernando
Núñez, Estefanía
Jorge, Inmaculada
Camafeita, Emilio
Mínguez, Pablo
Rodriguez de Córdoba, Santiago
López-Melgar, Beatriz
Lara-Pezzi, Enrique
Fernández-Ortiz, Antonio
Ibáñez, Borja
Valdivielso, José Manuel
Fuster Carulla, Valentí
Michel, Jean-Baptiste
Blanco-Colio, Luis Miguel
Vázquez, Jesús
Martín Ventura, José Luis
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Departamento de Medicina
Facultad de Medicina
dc.subject.none.fl_str_mv Biomarkers
Complement system
Proteomics
Subclinical atherosclerosis
Medicina
topic Biomarkers
Complement system
Proteomics
Subclinical atherosclerosis
Medicina
description Background: The mechanisms underlying early atherosclerotic plaque formation are not completely understood. Moreover, plasma biomarkers of subclinical atherosclerosis are lacking. Objectives: The purpose of this study was to analyze the temporal and topologically resolved protein changes taking place in human aortas with early atherosclerosis to find new potential diagnostic and/or therapeutic targets. Methods: The protein composition of healthy aortas (media layer) or with early atheroma (fatty streak and fibrolipidic, media and intima layers) was analyzed by deep quantitative multiplexed proteomics. Further analysis was performed by Western blot, immunohistochemistry, real-time polymerase chain reaction, and enzyme-linked immunosorbent assay. Plasma levels of complement C5 were analyzed in relation to the presence of generalized (>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical cohorts (PESA [Progression of Early Subclinical Atherosclerosis] [n = 360] and NEFRONA [National Observatory of Atherosclerosis in Nephrology] [n = 394]). Results: Proteins involved in lipid transport, complement system, immunoglobulin superfamily, and hemostasis are increased in early plaques. Components from the complement activation pathway were predominantly increased in the intima of fibrolipidic plaques. Among them, increased C5 protein levels were further confirmed by Western blot, enzyme-linked immunosorbent assay and immunohistochemistry, and associated with in situ complement activation. Plasma C5 was significantly increased in individuals with generalized subclinical atherosclerosis in both PESA and NEFRONA cohorts, independently of risk factors. Moreover, in the PESA study, C5 plasma levels positively correlated with global plaque volume and coronary calcification. Conclusions: Activation of the complement system is a major alteration in early atherosclerotic plaques and is reflected by increased C5 plasma levels, which have promising value as a novel circulating biomarker of subclinical atherosclerosis
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-04-28
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/10486/693219
https://dx.doi.org/10.1016/j.jacc.2020.02.058
url http://hdl.handle.net/10486/693219
https://dx.doi.org/10.1016/j.jacc.2020.02.058
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier Inc.
publisher.none.fl_str_mv Elsevier Inc.
dc.source.none.fl_str_mv reponame:Biblos-e Archivo. Repositorio Institucional de la UAM
instname:Universidad Autónoma de Madrid
instname_str Universidad Autónoma de Madrid
reponame_str Biblos-e Archivo. Repositorio Institucional de la UAM
collection Biblos-e Archivo. Repositorio Institucional de la UAM
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869409383843102720
score 15.301603